Cargando…
Drug repositioning, a new alternative in infectious diseases
Autores principales: | Serafin, Marissa Bolson, Hörner, Rosmari |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425657/ https://www.ncbi.nlm.nih.gov/pubmed/29963991 http://dx.doi.org/10.1016/j.bjid.2018.05.007 |
Ejemplares similares
-
Drug repositioning is an alternative for the treatment of coronavirus COVID-19
por: Serafin, Marissa B., et al.
Publicado: (2020) -
Selective serotonin reuptake inhibitor (SSRI) antidepressants reduce COVID-19 infection: prospects for use
por: Foletto, Vitória Segabinazzi, et al.
Publicado: (2022) -
Anti-infective properties of proton pump inhibitors: perspectives
por: da Rosa, Taciéli Fagundes, et al.
Publicado: (2021) -
Colistin resistance in non-fermenting Gram-negative bacilli in a university hospital
por: Santos, Silvana Oliveira dos, et al.
Publicado: (2016) -
Drug repositioning can accelerate discovery of pharmacological chaperones
por: Hay Mele, Bruno, et al.
Publicado: (2015)